Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Basking Biosciences, a US-based pharmaceutical firm linked to Duke University and Ohio State University (OSU), has closed a $5.4m series seed round featuring OSU-backed Rev1 Ventures, Broadview Ventures and Viva BioInnovation, the venture capital arm of drug discovery holding company Viva Biotech. Founded in 2019, Basking Biosciences is working on a drug treatment for acute…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.